A highly anticipated trial in sub-Saharan Africa is the first to specifically evaluate the efficacy of a COVID-19 vaccine in people living with HIV.
“Retention is a chronic challenge” in clinical trials. A key to overcoming it is physician engagement, expert says.
Early approval pathways for drugs often result in access accompanied by a persistent lack of evidence of benefit, experts say.
Expert says “we’ve taken a step back” over the past few months in embracing DCTs.
Technology can significantly enhance clinical trial productivity and reach, “but it can get messy” if it’s not handled properly before, during, and after implementation.